News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,347 Results
Type
Article (41198)
Company Profile (265)
Press Release (684869)
Multimedia
Podcasts (89)
Webinars (20)
Section
Business (204796)
Career Advice (2029)
Deals (35570)
Drug Delivery (122)
Drug Development (81478)
Employer Resources (173)
FDA (16478)
Job Trends (14969)
News (346723)
Policy (32767)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2584)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49611)
ALS (192)
Alzheimer's disease (1741)
Antibody-drug conjugate (ADC) (380)
Approvals (16794)
Artificial intelligence (596)
Autoimmune disease (222)
Automation (50)
Bankruptcy (362)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (174)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (689)
Cancer (5311)
Cardiovascular disease (442)
Career advice (1718)
Career pathing (39)
CAR-T (298)
CDC (53)
Celiac Disease (2)
Cell therapy (796)
Cervical cancer (41)
Clinical research (70232)
Collaboration (1887)
Company closure (4)
Compensation (1257)
Complete response letters (69)
COVID-19 (2724)
CRISPR (98)
C-suite (972)
Cystic fibrosis (148)
Data (7036)
Decentralized trials (3)
Denatured (26)
Depression (152)
Dermatology (57)
Diabetes (549)
Diagnostics (6823)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (292)
Drug pricing (196)
Drug shortages (29)
Duchenne muscular dystrophy (265)
Earnings (91057)
Editorial (61)
Employer branding (21)
Employer resources (152)
Events (118328)
Executive appointments (1030)
FDA (19889)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1605)
Gene editing (210)
Generative AI (52)
Gene therapy (651)
GLP-1 (1015)
Government (4693)
Grass and pollen (6)
Guidances (396)
Healthcare (18920)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (271)
Immuno-oncology (80)
Indications (157)
Infectious disease (3036)
Inflammatory bowel disease (200)
Inflation Reduction Act (15)
Influenza (128)
Intellectual property (273)
Interviews (316)
IPO (16650)
IRA (50)
Job creations (3648)
Job search strategy (1431)
JPM (59)
Kidney cancer (18)
Labor market (92)
Layoffs (553)
Leadership (34)
Legal (7958)
Liver cancer (98)
Longevity (28)
Lung cancer (719)
Lymphoma (406)
Machine learning (52)
Management (59)
Manufacturing (915)
MASH (176)
Medical device (13850)
Medtech (13927)
Mergers & acquisitions (20076)
Metabolic disorders (1408)
mRNA (173)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (380)
Neuropsychiatric disorders (97)
Neuroscience (3126)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4525)
Now hiring (74)
Obesity (663)
Opinion (277)
Ovarian cancer (185)
Pain (227)
Pancreatic cancer (253)
Parkinson's disease (336)
Partnered (33)
Patents (554)
Patient recruitment (587)
Peanut (60)
People (59225)
Pharmaceutical (60)
Pharmacy benefit managers (31)
Phase 1 (21887)
Phase 2 (30918)
Phase 3 (23038)
Pipeline (7084)
Policy (302)
Postmarket research (2566)
Preclinical (9276)
Press Release (64)
Prostate cancer (275)
Psychedelics (50)
Radiopharmaceuticals (303)
Rare diseases (988)
Real estate (5958)
Recruiting (70)
Regulatory (24968)
Reports (54)
Research institute (2405)
Resumes & cover letters (353)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (164)
Series A (266)
Series B (199)
Service/supplier (11)
Sickle cell disease (106)
Special edition (23)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3626)
State (2)
Stomach cancer (19)
Supply chain (117)
Tariffs (85)
The Weekly (61)
Vaccines (1054)
Venture capital (98)
Weight loss (422)
Women's health (108)
Worklife (19)
Date
Today (167)
Last 7 days (742)
Last 30 days (2747)
Last 365 days (29985)
2026 (7926)
2025 (30182)
2024 (35230)
2023 (40087)
2022 (51180)
2021 (55714)
2020 (54090)
2019 (46545)
2018 (35021)
2017 (32113)
2016 (31483)
2015 (37554)
2014 (31321)
2013 (26347)
2012 (28575)
2011 (29270)
2010 (27337)
Location
Africa (738)
Alabama (89)
Alaska (7)
Arizona (331)
Arkansas (14)
Asia (39501)
Australia (6454)
California (12237)
Canada (3502)
China (1224)
Colorado (520)
Connecticut (520)
Delaware (366)
Europe (85237)
Florida (1847)
Georgia (393)
Hawaii (3)
Idaho (62)
Illinois (954)
India (79)
Indiana (557)
Iowa (22)
Japan (485)
Kansas (129)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1481)
Massachusetts (8737)
Michigan (346)
Minnesota (673)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (82)
New Jersey (3267)
New Mexico (28)
New York (3225)
North Carolina (1551)
North Dakota (8)
Northern California (6051)
Ohio (365)
Oklahoma (22)
Oregon (41)
Pennsylvania (2478)
Puerto Rico (25)
Rhode Island (50)
South America (1111)
South Carolina (76)
South Dakota (1)
Southern California (4808)
Tennessee (199)
Texas (1920)
United States (43336)
Utah (365)
Vermont (1)
Virginia (291)
Washington D.C. (80)
Washington State (980)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
726,347 Results for "daiichi sankyo inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antibody-drug conjugate (ADC)
Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline
DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo
April 2, 2026
·
7 min read
Press Releases
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
January 22, 2026
·
3 min read
Press Releases
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
February 19, 2026
·
2 min read
Lung cancer
Merck, Daiichi Sankyo Stage Lung Cancer Rally With ‘Strong’ Pivotal Data for I-Dxd
According to analysts, the new data could present a path to accelerated approval for ifinatamab deruxtecan, a product of Merck and Daiichi Sankyo’s troubled ADC partnership.
September 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Technology
February 23, 2026
·
1 min read
Press Releases
Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Technology for Next-Generation Tumor-Activated ADCs
March 17, 2026
·
2 min read
Press Releases
Tempus Announces Strategic Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Clinical Differentiation Across an ADC Clinical Program
March 25, 2026
·
4 min read
Press Releases
Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologics Using Next-Gen In Vivo Antibody Discovery Platforms
March 18, 2026
·
1 min read
Press Releases
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.
March 5, 2026
·
5 min read
1 of 72,635
Next
